Gamida Cell Ltd., of Boston, and Minneapolis-based Be The Match Biotherapies, a subsidiary of the National Marrow Donor Program/Be The Match, are collaborating on the ongoing development of Gamida's cell therapy, Nicord. Be The Match Biotherapies will provide research assets and services, including access to its Be The Match Registry.